ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
University of Bordeaux
Burdeos, FranciaPublicacións en colaboración con investigadores/as de University of Bordeaux (2)
2024
-
Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)
Journal of Clinical Pharmacology, Vol. 64, Núm. 5, pp. 544-554
2022
-
First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma
Cancer Immunology, Immunotherapy, Vol. 71, Núm. 2, pp. 417-431